📰 Jack Weinstein News
Page 28 - Jack Weinstein News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jack Weinstein. Real-time updates on events, politics, business and more.
January 27, 2022
EQS-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Conference Acer Therapeutics and Relief Therapeutics Announce Presentation of Four ACER-001 Posters at the Upcoming SIMD and GMDI Conferences 27-Jan-2022 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer...
January 27, 2022
RELIEF THERAPEUTICS Holding AG / Key word(s): Research Update27-Jan-2022 / 07:15 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Reports that its U.S. Collaboration Partner has Announced Receipt of Initial Report of Patient...
January 27, 2022
GuruFocus Article or News written by GuruFocusNews and the topic is about:
January 27, 2022
EQS-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Research Update Relief Reports that its U.S. Collaboration Partner has Announced Receipt of Initial Report of Patient Safety and Survival from
January 27, 2022
RELIEF THERAPEUTICS Holding AG / Key word(s): Conference27-Jan-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Acer Therapeutics and Relief Therapeutics Announce Presentation of Four ACER-001 Posters at the Upcoming SI...
January 27, 2022
EQS-Ad-hoc: Relief Therapeutics Holding AG / Key word(s): Conference Acer Therapeutics and Relief Therapeutics Announce Presentation of Four A...
January 24, 2022
EQS-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Patent Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application
January 24, 2022
RELIEF THERAPEUTICS Holding AG / Key word(s): Patent24-Jan-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key...
January 24, 2022
EQS-Ad-hoc: Relief Therapeutics Holding AG / Key word(s): Patent Relief Therapeutics Wholly Owned Subsidiary, APR Applied Pharma Research, Re...
January 19, 2022
EQS-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Miscellaneous Relief Reports US Collaboration Partner Announces Expansion of Aviptadil US Expanded Access & Right to Try Programs for Patients